P2Y 12 H2 Haplotype Is Associated With Peripheral Arterial Disease
- 16 December 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (24) , 2971-2973
Abstract
Background— We recently described a gain-of-function haplotype, called H2, of the adenosine diphosphate (ADP) receptor P2Y 12 gene associated with increased ADP-induced platelet aggregation ex vivo in healthy volunteers. Because platelets play a key role in atherosclerosis and arterial thrombosis, we tested the possible link between the H2 haplotype and the risk of peripheral arterial disease (PAD) in a case-control study. Methods and Results— We studied 184 consecutive male patients under 70 years of age with PAD and 330 age-matched control subjects free of symptomatic PAD and with no cardiovascular history. Mean age was 57.1±7.2 years (cases) and 56.7±7.6 years (control subjects). The H2 haplotype was more frequent in patients with PAD than in control subjects (30% and 21%, respectively; OR, 1.6; CI, 1.1 to 2.5; P =0.02 in univariate analysis). This association with PAD remained significant in multivariate regression analysis (OR, 2.3; CI, 1.4 to 3.9; P =0.002) after adjustment for diabetes, smoking, hypertension, hypercholesterolemia, and other selected platelet receptor gene polymorphisms. Conclusions— These data point to a role of the H2 haplotype in atherosclerosis and raise the possibility of relative thienopyridine resistance in carriers of the P2Y 12 H2 haplotype.Keywords
This publication has 11 references indexed in Scilit:
- Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosisCurrent Opinion in Hematology, 2003
- Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With
P2Y
12
Gene Sequence Variations in Healthy SubjectsCirculation, 2003
- An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRNBlood, 2003
- Peripheral arterial diseaseThe Lancet, 2001
- Identification of the platelet ADP receptor targeted by antithrombotic drugsNature, 2001
- ADP Receptors of Platelets and their InhibitionThrombosis and Haemostasis, 2001
- Platelet glycoprotein polymorphisms as risk factors for thrombosisCurrent Opinion in Hematology, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismBritish Journal of Haematology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996